In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking

被引：0
|
作者：
Liang-qin Gao
Jing Xu
Shao-dong Chen
机构：
[1] Xiamen University,Department of Traditional Chinese Medicine, Xiamen University Hospital
[2] Xiamen University,College of Ocean and Earth Sciences
[3] Xiamen University,Department of Traditional Chinese Medicine, School of Medicine
来源：
Chinese Journal of Integrative Medicine | 2020年 / 26卷
关键词：
molecular docking; COVID-19; SARS-CoV-2 3CL hydrolytic enzyme; angiotensin converting enzyme II; Chinese medicine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：527 / 532
页数：5
相关论文
共 50 条
  • [1] In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme Ⅱ Using Molecular Docking
    GAO Liang-qin
    XU Jing
    CHEN Shao-dong
    Chinese Journal of Integrative Medicine, 2020, (07) : 527 - 532
  • [2] In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme Ⅱ Using Molecular Docking
    GAO Liangqin
    XU Jing
    CHEN Shaodong
    Chinese Journal of Integrative Medicine, 2020, 26 (07) : 527 - 532
  • [3] In SilicoScreening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking
    Gao, Liang-qin
    Xu, Jing
    Chen, Shao-dong
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2020, 26 (07) : 527 - 532
  • [4] An in silico molecular dynamics simulation study on the inhibitors of SARS-CoV-2 proteases (3CLpro and PLpro) to combat COVID-19
    Bera, Krishnendu
    Reeda, V. S. Jeba
    Babila, P. R.
    Dinesh, Dhurvas Chandrasekaran
    Hritz, Jozef
    Karthick, T.
    MOLECULAR SIMULATION, 2021, 47 (14) : 1168 - 1184
  • [5] Chetomin, a SARS-CoV-2 3C-like Protease (3CLpro) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis
    Ibrahim, Mahmoud A. A.
    Abdelrahman, Alaa H. M.
    Mohamed, Dina E. M.
    Abdeljawaad, Khlood A. A.
    Naeem, Mohamed Ahmed
    Gabr, Gamal A.
    Shawky, Ahmed M.
    Soliman, Mahmoud E. S.
    Sidhom, Peter A.
    Pare, Paul W.
    Hegazy, Mohamed-Elamir F.
    VIRUSES-BASEL, 2023, 15 (01):
  • [6] In silico and in vitro assays reveal potential inhibitors against 3CLpro main protease of SARS-CoV-2
    Iype, Eldhose
    Jisha, Pillai U.
    Kumar, Indresh
    Gaastra-Nedea, Silvia V.
    Subramanian, Ramachandran
    Saha, Ranendra Narayan
    Dutta, Mainak
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (23): : 12800 - 12811
  • [7] Chinese herbal medicine for SARS and SARS-CoV-2 treatment and prevention, encouraging using herbal medicine for COVID-19 outbreak
    Shahrajabian, Mohamad Hesam
    Sun, Wenli
    Shen, Hong
    Cheng, Qi
    ACTA AGRICULTURAE SCANDINAVICA SECTION B-SOIL AND PLANT SCIENCE, 2020, 70 (05): : 437 - 443
  • [8] In Silico Molecular Docking and Molecular Dynamic Simulation Analysis of Phytochemicals From Indian Foods as Potential Inhibitors of SARS-CoV-2 RdRp and 3CLpro
    Qazi, Sahar
    Das, Soumi
    Khuntia, Bharat Krushna
    Sharma, Vandna
    Sharma, Shruti
    Sharma, Gautam
    Raza, Khalid
    NATURAL PRODUCT COMMUNICATIONS, 2021, 16 (09)
  • [9] Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking
    Yu, Ran
    Chen, Liang
    Lan, Rong
    Shen, Rong
    Li, Peng
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (02)
  • [10] Identification of potential antivirals against 3CLpro enzyme for the treatment of SARS-CoV-2: A multi-step virtual screening study
    Kumar, V
    Kar, S.
    De, P.
    Roy, K.
    Leszczynski, J.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2022, 33 (05) : 357 - 386
12345